Ticker
VYNECompany Name
VYNE THERAPEUTICS INCSector
HealthcareIndustry
BiotechnologyExchange
NASDAQDate | Total Assets | Cash and Equivalents | Core Assets | Goodwill and Intangibles |
---|---|---|---|---|
6/30/2025 | $ 44.72M | $ 22.05M | $ 22.67M | $ 0 |
3/31/2025 | $ 56.42M | $ 28.21M | $ 28.21M | $ 0 |
12/31/2024 | $ 66.91M | $ 19.93M | $ 46.98M | $ 0 |
9/30/2024 | $ 76.2M | $ 16.32M | $ 59.88M | $ 0 |
6/30/2024 | $ 86.65M | $ 29.66M | $ 56.99M | $ 0 |
3/31/2024 | $ 91.68M | $ 19.12M | $ 72.56M | $ 0 |
12/31/2023 | $ 97.69M | $ 30.67M | $ 67.01M | $ 0 |
9/30/2023 | $ 19.27M | $ 15.5M | $ 3.77M | $ 0 |
6/30/2023 | $ 24.96M | $ 20.7M | $ 4.26M | $ 0 |
3/31/2023 | $ 35.26M | $ 30.28M | $ 4.98M | $ 0 |
We picked the following companies as peers based on multiple factors, including sector, industry, market capitalization and revenue
Assets - Intangibles - CashnEq
(=) Core Assets
Core Assets for VYNE THERAPEUTICS INC is calculated as follows: Assets [ $ 107.68M ] - Intangibles [ $ 0 ] - CashnEq [ $ 73.81M ]
(=) Core Assets [ $ 33.87M ]
Minimum
Sep 30, 2023
Maximum
Mar 31, 2024
Average
Median
filtered constituents | 3.42K |
---|---|
min | $ 0 |
max | $ 4.42B |
average | $ 805.95M |
median | $ 292.02M |
std | $ 1.06B |